EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study

Caroline Minassian iD, Lowri A Allen, Onyebuchi Okosieme, Bijay Vaidya, Peter Taylor iD

The Journal of Clinical Endocrinology & Metabolism · 18.10.2023 · 108 (11) · 2886-2897

DOI: 10.1210/clinem/dgad276 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 18.05.2023. Verfasst von Caroline Minassian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Epidemiology and Population Health, Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, L…. Hauptthemen laut MEDLINE: Thyroxine, Hyperthyroidism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UK Research and Innovation Fellowship, British Thyroid Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Optimal thyroid status in pregnancy is essential in reducing the risk of adverse outcomes. The management of hyperthyroidism in women of reproductive age poses unique challenges and it is unclear how preconception treatment strategies impact on thyroid status in subsequent pregnancy.

Objective

We aimed to determine trends in the management of hyperthyroidism before and during pregnancy and to assess the impact of different preconception treatment strategies on maternal thyroid status.

Methods

We utilized the Clinical Practice Research Datalink database to evaluate all females aged 15-45 years with a clinical diagnosis of hyperthyroidism and a subsequent pregnancy (January 2000 to December 2017). We compared thyroid status in pregnancy according to preconception treatment, namely, (1) antithyroid drugs up to or beyond pregnancy onset, (2) definitive treatment with thyroidectomy or radioiodine before pregnancy, and (3) no treatment at pregnancy onset.

Results

Our study cohort comprised 4712 pregnancies. Thyrotropin (TSH) was measured in only 53.1% of pregnancies, of which 28.1% showed suboptimal thyroid status (TSH >4.0 mU/L or TSH <0.1 mU/L plus FT4 >reference range). Pregnancies with prior definitive treatment were more likely to have suboptimal thyroid status compared with pregnancies starting during antithyroid drug treatment (odds ratio 4.72, 95% CI 3.50-6.36). A steady decline in the use of definitive treatment before pregnancy was observed from 2000 to 2017. One-third (32.6%) of first trimester carbimazole-exposed pregnancies were switched to propylthiouracil while 6.0% of propylthiouracil-exposed pregnancies switched to carbimazole.

Conclusion

The management of women with hyperthyroidism who become pregnant is suboptimal, particularly in those with preconception definitive treatment, and needs urgent improvement. Better thyroid monitoring and prenatal counseling are needed to optimize thyroid status, reduce teratogenic drug exposure, and ultimately reduce the risk of adverse pregnancy outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineHyperthyroidismPregnancyFemaleHumansPropylthiouracilCarbimazoleIodine RadioisotopesCohort StudiesThyrotropinAntithyroid AgentsThyroid Function Tests

Stichwörter der Autor:innen

CPRDFT3FT4PTUTSHcarbimazolehyperthyroidismpregnancythyroid functionthyroid stimulating hormonethyroxinetri-iodothyronine

Substanzen

ThyroxinePropylthiouracilCarbimazoleIodine RadioisotopesThyrotropinAntithyroid Agents

Autor:innen und Institutionen

  • Faculty of Epidemiology and Population Health, Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
  • Diabetes Research Group, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
  • Thyroid Research Group, Systems Immunity Research Institute Medicine, Cardiff University School of Medicine, Cardiff CF14 4XN, UK.
  • Department of Endocrinology, Royal Devon & Exeter Hospital, University of Exeter Medical School, Exeter EX2 5DW, UK.

ORCID-Profile: Caroline Minassian, Peter Taylor

Förderung

  • Medical Research Council
  • UK Research and Innovation Fellowship
  • British Thyroid Foundation

Zitieren

APA

Minassian, C., Allen, L. A., Okosieme, O., Vaidya, B., & Taylor, P. (2023). Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study. The Journal of Clinical Endocrinology & Metabolism, 108(11), 2886-2897. https://doi.org/10.1210/clinem/dgad276

Vancouver

Minassian C, Allen LA, Okosieme O, Vaidya B, Taylor P. Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2023;108(11):2886-2897. doi:10.1210/clinem/dgad276

BibTeX
@article{Minassian2023,
  author = {Minassian, Caroline and Allen, Lowri A and Okosieme, Onyebuchi and Vaidya, Bijay and Taylor, Peter},
  title = {Preconception Management of Hyperthyroidism and Thyroid Status in Subsequent Pregnancy: A Population-Based Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {11},
  pages = {2886--2897},
  doi = {10.1210/clinem/dgad276}
}
Kostenlos starten →